Global Candesartan and Hydrochlorothiazide market is expected to grow from US$ 355 million in 2025 to US$ 521 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

Global Candesartan and Hydrochlorothiazide Market Size and Outlook 2025-31

The global Candesartan and Hydrochlorothiazide market size is predicted to grow from US$ 355 million in 2025 to US$ 521 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or water pills). This combination medication is used to lower high blood pressure. United States market for Candesartan and Hydrochlorothiazide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Candesartan and Hydrochlorothiazide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Candesartan and Hydrochlorothiazide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Candesartan and Hydrochlorothiazide players cover AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddys Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Candesartan and Hydrochlorothiazide Industry Forecast looks at past sales and reviews total world Candesartan and Hydrochlorothiazide sales in 2024, providing a comprehensive analysis by region and market sector of projected Candesartan and Hydrochlorothiazide sales for 2025 through 2031. With Candesartan and Hydrochlorothiazide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Candesartan and Hydrochlorothiazide industry. This Insight Report provides a comprehensive analysis of the global Candesartan and Hydrochlorothiazide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Candesartan and Hydrochlorothiazide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Candesartan and Hydrochlorothiazide market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Candesartan and Hydrochlorothiazide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Candesartan and Hydrochlorothiazide. This report presents a comprehensive overview, market shares, and growth opportunities of Candesartan and Hydrochlorothiazide market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 16/12.5 &nbsp;&nbsp;&nbsp; 32/12.5 &nbsp;&nbsp;&nbsp; 32/25 Segmentation by Application: &nbsp;&nbsp;&nbsp; Adults &nbsp;&nbsp;&nbsp; Geriatric This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; ANI Pharmaceuticals &nbsp;&nbsp;&nbsp; TEVA &nbsp;&nbsp;&nbsp; Mylan &nbsp;&nbsp;&nbsp; Dr. Reddys Laboratories &nbsp;&nbsp;&nbsp; Zydus Pharmaceuticals &nbsp;&nbsp;&nbsp; Prinston Pharmaceutical &nbsp;&nbsp;&nbsp; MACLEODS Key Questions Addressed in this Report What is the 10-year outlook for the global Candesartan and Hydrochlorothiazide market? What factors are driving Candesartan and Hydrochlorothiazide market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Candesartan and Hydrochlorothiazide market opportunities vary by end market size? How does Candesartan and Hydrochlorothiazide break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Candesartan and Hydrochlorothiazide Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Candesartan and Hydrochlorothiazide by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Candesartan and Hydrochlorothiazide by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Candesartan and Hydrochlorothiazide Segment by Type &nbsp;2.2.1 16/12.5 &nbsp;2.2.2 32/12.5 &nbsp;2.2.3 32/25 &nbsp;2.3 Candesartan and Hydrochlorothiazide Sales by Type &nbsp;2.3.1 Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Candesartan and Hydrochlorothiazide Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Candesartan and Hydrochlorothiazide Sale Price by Type (2020-2025) &nbsp;2.4 Candesartan and Hydrochlorothiazide Segment by Application &nbsp;2.4.1 Adults &nbsp;2.4.2 Geriatric &nbsp;2.5 Candesartan and Hydrochlorothiazide Sales by Application &nbsp;2.5.1 Global Candesartan and Hydrochlorothiazide Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Candesartan and Hydrochlorothiazide Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Candesartan and Hydrochlorothiazide Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Candesartan and Hydrochlorothiazide Breakdown Data by Company &nbsp;3.1.1 Global Candesartan and Hydrochlorothiazide Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Candesartan and Hydrochlorothiazide Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Candesartan and Hydrochlorothiazide Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Company (2020-2025) &nbsp;3.2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Candesartan and Hydrochlorothiazide Sale Price by Company &nbsp;3.4 Key Manufacturers Candesartan and Hydrochlorothiazide Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Candesartan and Hydrochlorothiazide Product Location Distribution &nbsp;3.4.2 Players Candesartan and Hydrochlorothiazide Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Candesartan and Hydrochlorothiazide by Geographic Region &nbsp;4.1 World Historic Candesartan and Hydrochlorothiazide Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Candesartan and Hydrochlorothiazide Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Candesartan and Hydrochlorothiazide Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Candesartan and Hydrochlorothiazide Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Candesartan and Hydrochlorothiazide Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Candesartan and Hydrochlorothiazide Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Candesartan and Hydrochlorothiazide Sales Growth &nbsp;4.4 APAC Candesartan and Hydrochlorothiazide Sales Growth &nbsp;4.5 Europe Candesartan and Hydrochlorothiazide Sales Growth &nbsp;4.6 Middle East & Africa Candesartan and Hydrochlorothiazide Sales Growth 5 Americas &nbsp;5.1 Americas Candesartan and Hydrochlorothiazide Sales by Country &nbsp;5.1.1 Americas Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) &nbsp;5.1.2 Americas Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) &nbsp;5.2 Americas Candesartan and Hydrochlorothiazide Sales by Type (2020-2025) &nbsp;5.3 Americas Candesartan and Hydrochlorothiazide Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Candesartan and Hydrochlorothiazide Sales by Region &nbsp;6.1.1 APAC Candesartan and Hydrochlorothiazide Sales by Region (2020-2025) &nbsp;6.1.2 APAC Candesartan and Hydrochlorothiazide Revenue by Region (2020-2025) &nbsp;6.2 APAC Candesartan and Hydrochlorothiazide Sales by Type (2020-2025) &nbsp;6.3 APAC Candesartan and Hydrochlorothiazide Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Candesartan and Hydrochlorothiazide by Country &nbsp;7.1.1 Europe Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) &nbsp;7.1.2 Europe Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) &nbsp;7.2 Europe Candesartan and Hydrochlorothiazide Sales by Type (2020-2025) &nbsp;7.3 Europe Candesartan and Hydrochlorothiazide Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Candesartan and Hydrochlorothiazide by Country &nbsp;8.1.1 Middle East & Africa Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Candesartan and Hydrochlorothiazide Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Candesartan and Hydrochlorothiazide Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Candesartan and Hydrochlorothiazide &nbsp;10.3 Manufacturing Process Analysis of Candesartan and Hydrochlorothiazide &nbsp;10.4 Industry Chain Structure of Candesartan and Hydrochlorothiazide 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Candesartan and Hydrochlorothiazide Distributors &nbsp;11.3 Candesartan and Hydrochlorothiazide Customer 12 World Forecast Review for Candesartan and Hydrochlorothiazide by Geographic Region &nbsp;12.1 Global Candesartan and Hydrochlorothiazide Market Size Forecast by Region &nbsp;12.1.1 Global Candesartan and Hydrochlorothiazide Forecast by Region (2026-2031) &nbsp;12.1.2 Global Candesartan and Hydrochlorothiazide Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Candesartan and Hydrochlorothiazide Forecast by Type (2026-2031) &nbsp;12.7 Global Candesartan and Hydrochlorothiazide Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 AstraZeneca &nbsp;13.1.1 AstraZeneca Company Information &nbsp;13.1.2 AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 AstraZeneca Main Business Overview &nbsp;13.1.5 AstraZeneca Latest Developments &nbsp;13.2 ANI Pharmaceuticals &nbsp;13.2.1 ANI Pharmaceuticals Company Information &nbsp;13.2.2 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 ANI Pharmaceuticals Main Business Overview &nbsp;13.2.5 ANI Pharmaceuticals Latest Developments &nbsp;13.3 TEVA &nbsp;13.3.1 TEVA Company Information &nbsp;13.3.2 TEVA Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 TEVA Main Business Overview &nbsp;13.3.5 TEVA Latest Developments &nbsp;13.4 Mylan &nbsp;13.4.1 Mylan Company Information &nbsp;13.4.2 Mylan Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Mylan Main Business Overview &nbsp;13.4.5 Mylan Latest Developments &nbsp;13.5 Dr. Reddy's Laboratories &nbsp;13.5.1 Dr. Reddy's Laboratories Company Information &nbsp;13.5.2 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Dr. Reddy's Laboratories Main Business Overview &nbsp;13.5.5 Dr. Reddy's Laboratories Latest Developments &nbsp;13.6 Zydus Pharmaceuticals &nbsp;13.6.1 Zydus Pharmaceuticals Company Information &nbsp;13.6.2 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Zydus Pharmaceuticals Main Business Overview &nbsp;13.6.5 Zydus Pharmaceuticals Latest Developments &nbsp;13.7 Prinston Pharmaceutical &nbsp;13.7.1 Prinston Pharmaceutical Company Information &nbsp;13.7.2 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.7.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Prinston Pharmaceutical Main Business Overview &nbsp;13.7.5 Prinston Pharmaceutical Latest Developments &nbsp;13.8 MACLEODS &nbsp;13.8.1 MACLEODS Company Information &nbsp;13.8.2 MACLEODS Candesartan and Hydrochlorothiazide Product Portfolios and Specifications &nbsp;13.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 MACLEODS Main Business Overview &nbsp;13.8.5 MACLEODS Latest Developments 14 Research Findings and Conclusion

Report	Global Candesartan and Hydrochlorothiazide Market Growth 2025-2031
Selected License	Multi ID: LPI25010

Buyer Information

Order Summary